Molecular recognition by the EWS transcriptional activation domain.

Interactions between Intrinsically Disordered Protein Regions (IDRs) and their targets commonly exhibit localised contacts via target-induced disorder to order transitions. Other more complex IDR target interactions have been termed "fuzzy" because the IDR does not form a well-defined induced structure. In some remarkable cases of fuzziness IDR function is apparently sequence independent and conferred by amino acid composition. Such cases have been referred to as "random fuzziness" but the molecular features involved are poorly characterised. The transcriptional activation domain (EAD) of oncogenic Ewing's Sarcoma Fusion Proteins (EFPs) is an ≈280 residue IDR with a biased composition restricted to Ala, Gly, Gln, Pro, Ser, Thr and Tyr. Multiple aromatic side chains (exclusively from Try residues) and the particular EAD composition are crucial for molecular recognition but there appears to be no other major geometrically constrained requirement. Computational analysis of the EAD using PONDR (Molecular Kinetics, Inc. http://www.pondr. com) complements the functional data and shows, accordingly, that propensity for structural order within the EAD is conferred by Tyr residues. To conclude, molecular recognition by the EAD is extraordinarily malleable and involves multiple aromatic contacts facilitated by a flexible peptide backbone and, most likely, a limited number of weaker contributions from amenable side chains. I propose to refer to this mode of fuzzy recognition as "polyaromatic", noting that it shares some fundamental features with the "polyelectrostatic" (phosphorylation-dependent) interaction of the Sic1 Cdk inhibitor and Cdc4._I will also speculate on more detailed models for molecular recognition by the EAD and their relationship to native (non-oncogenic) EAD function.

[1]  Ewings family oncoproteins: drunk, disorderly and in search of partners , 2007, Cell Research.

[2]  A. Fukamizu,et al.  Cooperative Interaction of EWS with CREB-binding Protein Selectively Activates Hepatocyte Nuclear Factor 4-mediated Transcription* , 2003, The Journal of Biological Chemistry.

[3]  P. Tompa.  Intrinsically unstructured proteins evolve by repeat expansion , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[4]  J. Manley,et al.  The TET family of proteins: functions and roles in disease. , 2009, Journal of molecular cell biology.

[5]  Zsuzsanna Dosztányi,et al.  IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content , 2005, Bioinform..

[6]  H. Chan,et al.  Polyelectrostatic interactions of disordered ligands suggest a physical basis for ultrasensitivity , 2007, Proceedings of the National Academy of Sciences.

[7]  Sonia Longhi,et al.  A practical overview of protein disorder prediction methods , 2006, Proteins.

[8]  V. Uversky,et al.  Why are “natively unfolded” proteins unstructured under physiologic conditions? , 2000, Proteins.

[9]  Liang Feng,et al.  A repetitive element containing a critical tyrosine residue is required for transcriptional activation by the EWS/ATF1 oncogene , 2001, Oncogene.

[10]  K. Melcher,et al.  The strength of acidic activation domains correlates with their affinity for both transcriptional and non-transcriptional proteins. , 2000, Journal of molecular biology.

[11]  D. Alex,et al.  RGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domains , 2005, Nucleic acids research.

[12]  Erica A Golemis,et al.  Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II , 1998, Oncogene.

[13]  C. Denny,et al.  Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene. , 1995, Oncogene.

[14]  Ralf Janknecht,et al.  EWS-ETS oncoproteins: the linchpins of Ewing tumors. , 2005, Gene.

[15]  István Simon,et al.  Preformed structural elements feature in partner recognition by intrinsically unstructured proteins. , 2004, Journal of molecular biology.

[16]  K. A. Lee,et al.  A monomeric derivative of the cellular transcription factor CREB functions as a constitutive activator , 1994, Molecular and cellular biology.

[17]  Monika Fuxreiter,et al.  Close encounters of the third kind: disordered domains and the interactions of proteins , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.

[18]  H. Kovar,et al.  Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein , 2003, Oncogene.

[19]  Eric D. Ross,et al.  Intrinsic Protein Disorder, Amino Acid Composition, and Histone Terminal Domains* , 2006, Journal of Biological Chemistry.

[20]  Christopher T Denny,et al.  Biology of EWS/ETS fusions in Ewing's family tumors , 2001, Oncogene.

[21]  H Kovar,et al.  O-GlcNAcylation is involved in the transcriptional activity of EWS-FLI1 in Ewing's sarcoma , 2009, Oncogene.

[22]  D. A. Dougherty,et al.  Cation-π interactions in structural biology , 1999 .

[23]  R. Janknecht,et al.  The Ewing's sarcoma gene product functions as a transcriptional activator. , 2001, Cancer research.

[24]  István Simon,et al.  Molecular principles of the interactions of disordered proteins. , 2007, Journal of molecular biology.

[25]  P. Tompa,et al.  Fuzzy complexes: polymorphism and structural disorder in protein-protein interactions. , 2008, Trends in biochemical sciences.

[26]  Christopher J. Oldfield,et al.  Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling , 2005, Journal of molecular recognition : JMR.

[27]  Tony Pawson,et al.  Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication , 2001, Nature.

[28]  Sarah Rauscher,et al.  Proline and glycine control protein self-organization into elastomeric or amyloid fibrils. , 2006, Structure.

[29]  L. Tora,et al.  The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties , 1999, Oncogene.

[30]  S. Pan,et al.  The EWS/ATF1 fusion protein contains a dispersed activation domain that functions directly , 1998, Oncogene.

[31]  Eric D Ross,et al.  Primary sequence independence for prion formation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Pelletier,et al.  Modification of EWS/WT1 functional properties by phosphorylation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Marc S. Cortese,et al.  Coupled folding and binding with α-helix-forming molecular recognition elements , 2005 .

[34]  H. Kovar,et al.  The Ewing family of tumors and the search for the Achilles' heel. , 1999, Current opinion in oncology.

[35]  Marc S. Cortese,et al.  Analysis of molecular recognition features (MoRFs). , 2006, Journal of molecular biology.

[36]  Maxim S. Pometun,et al.  Quantitative Observation of Backbone Disorder in Native Elastin* , 2004, Journal of Biological Chemistry.

[37]  Zheng Rong Yang,et al.  RONN: the bio-basis function neural network technique applied to the detection of natively disordered regions in proteins , 2005, Bioinform..

[38]  Olivier Delattre,et al.  EWS, but Not EWS-FLI-1, Is Associated with Both TFIID and RNA Polymerase II: Interactions between Two Members of the TET Family, EWS and hTAFII68, and Subunits of TFIID and RNA Polymerase II Complexes , 1998, Molecular and Cellular Biology.

[39]  J. Toretsky,et al.  Recombinant EWS-FLI1 oncoprotein activates transcription. , 2004, Biochemistry.

[40]  B. Graveley,et al.  Arginine/serine repeats are sufficient to constitute a splicing activation domain. , 2003, Nucleic acids research.

[41]  A. Sigalov,et al.  The intrinsically disordered cytoplasmic domain of the T cell receptor zeta chain binds to the nef protein of simian immunodeficiency virus without a disorder-to-order transition. , 2008, Biochemistry.

[42]  A Keith Dunker,et al.  Intrinsic disorder in scaffold proteins: getting more from less. , 2008, Progress in biophysics and molecular biology.

[43]  Zoran Obradovic,et al.  Predicting intrinsic disorder from amino acid sequence , 2003, Proteins.

[44]  Jaime Prilusky,et al.  FoldIndex copyright: a simple tool to predict whether a given protein sequence is intrinsically unfolded , 2005, Bioinform..

[45]  G. C. Walker,et al.  Regulation of Escherichia coli SOS mutagenesis by dimeric intrinsically disordered umuD gene products , 2008, Proceedings of the National Academy of Sciences.

[46]  G. Hicks,et al.  TLS, EWS and TAF15: a model for transcriptional integration of gene expression. , 2006, Briefings in functional genomics & proteomics.

[47]  S. L. Wong,et al.  Towards a proteome-scale map of the human protein–protein interaction network , 2005, Nature.

[48]  P. Tompa,et al.  Limitations of induced folding in molecular recognition by intrinsically disordered proteins. , 2009, Chemphyschem : a European journal of chemical physics and physical chemistry.

[49]  J. Pelletier,et al.  The DNA binding domains of the WT1 tumor suppressor gene product and chimeric EWS/WT1 oncoprotein are functionally distinct , 1998, Oncogene.

[50]  J. Pelletier,et al.  Molecular genetics of chromosome translocations involving EWS and related family members. , 1999, Physiological genomics.

[51]  Adel Golovin,et al.  Cation–π interactions in protein–protein interfaces , 2005 .

[52]  Lilia M. Iakoucheva,et al.  Intrinsic Disorder Is a Common Feature of Hub Proteins from Four Eukaryotic Interactomes , 2006, PLoS Comput. Biol..

[53]  Vladimir N Uversky,et al.  Multiple aromatic side chains within a disordered structure are critical for transcription and transforming activity of EWS family oncoproteins , 2007, Proceedings of the National Academy of Sciences.

[54]  L. Iakoucheva,et al.  The importance of intrinsic disorder for protein phosphorylation. , 2004, Nucleic acids research.

[55]  Christopher J. Oldfield,et al.  Intrinsic disorder in transcription factors. , 2006, Biochemistry.

[56]  István Simon,et al.  BIOINFORMATICS ORIGINAL PAPER doi:10.1093/bioinformatics/btm035 Structural bioinformatics Local structural disorder imparts plasticity on linear motifs , 2022 .

[57]  S. Li.  Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction. , 2005, The Biochemical journal.

[58]  R. Reithmeier,et al.  Topology of transmembrane segments 1-4 in the human chloride/bicarbonate anion exchanger 1 (AE1) by scanning N-glycosylation mutagenesis. , 2005, The Biochemical journal.

[59]  R. Ebright,et al.  Mutational analysis of a transcriptional activation region of the VP16 protein of herpes simplex virus. , 1998, Nucleic acids research.

[60]  J. Pelletier,et al.  Modulation of EWS/WT1 activity by the v‐Src protein tyrosine kinase , 2000, FEBS letters.

[61]  K K Li,et al.  Transcriptional Activation by the Ewing's Sarcoma (EWS) Oncogene Can Be Cis-repressed by the EWS RNA-binding Domain* , 2000, The Journal of Biological Chemistry.

[62]  Peter Tompa,et al.  Primary contact sites in intrinsically unstructured proteins: the case of calpastatin and microtubule-associated protein 2. , 2005, Biochemistry.

[63]  King Pan Ng,et al.  In vitro activity of the EWS oncogene transcriptional activation domain. , 2009, Biochemistry.

[64]  J. Thornton,et al.  Structural characterisation and functional significance of transient protein-protein interactions. , 2003, Journal of molecular biology.

[65]  K. A. Lee,et al.  Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF1 oncogene. , 1995, Oncogene.

[66]  Leo M. Lee,et al.  EWS-ATF-1 chimeric protein in soft tissue clear cell sarcoma associates with CREB-binding protein and interferes with p53-mediated trans-activation function , 2001, Oncogene.

[67]  P. Chambon,et al.  hTAF(II)68, a novel RNA/ssDNA‐binding protein with homology to the pro‐oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. , 1996, The EMBO journal.

[68]  R. Russell,et al.  Linear motifs: Evolutionary interaction switches , 2005, FEBS letters.

[69]  Huiqing Zhou,et al.  An hsRPB4/7-dependent yeast assay for trans-activation by the EWS oncogene , 2001, Oncogene.